Company profile: Liberation Labs
1.1 - Company Overview
Company description
- Provider of industrial biotechnology infrastructure for agriculture, offering the Bio3 global precision fermentation platform, high-yield fermentation facilities, efficient fermentation processes with multiple feed capabilities and continuous sterilization, and downstream recovery using centrifugation, microfiltration and ultrafiltration to retain proteins and produce shelf-stable bioproducts.
Products and services
- Bio3 TM: An industrial-grade global biomanufacturing platform architected for precision fermentation, enhancing cost-efficiency and yields for novel bioproducts
- Fermentation Process: A custom-engineered fermentation process integrating multiple feed capabilities and continuous sterilization, delivering efficient, flexible biomanufacturing
- Precision Fermentation Facilities: Industrial-scale facilities engineered for high-yield production of sustainable alternatives, adaptable to a significant portion of the bioproducts market.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Liberation Labs
The Medicine Maker
HQ: United Kingdom
Website
- Description: Provider of a publication for persons involved in the development and manufacture of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicine Maker company profile →
GL Chemtec
HQ: Canada
Website
- Description: Provider of custom small-molecule API discovery, process development, scale-up and manufacturing for life sciences; tailored biomedical polymers and hydrogels for drug delivery and medical devices (including silicone hydrogels, functionalized biopolymers, emulsions, synthetic organoids); integrated drug-delivery solutions combining small-molecule chemistry and polymer design; and analytical method development and transfer, stability studies and sample analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GL Chemtec company profile →
Prescient
HQ: United Kingdom
Website
- Description: Provider of product strategy and decision support consultancy that helps clients make better clinical and commercial decisions, enhancing outcomes for patients, customers and shareholders. Founded in London and originally specializing in competitive insights, with a global reach through offices in New York, San Francisco, New Delhi and Beijing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prescient company profile →
Lyophilization Services
HQ: United States
Website
- Description: Provider of lyophilization services to the pharmaceutical, biotechnology, and medical device industries, producing products in a timely, reliably consistent, GMP-compliant manner with a focus on quality and patient safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lyophilization Services company profile →
CBPartners
HQ: United States
Website
- Description: Provider of strategy consulting services focused on strategic issues for multinational pharmaceutical, biopharmaceutical, and medical device companies, as well as governments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CBPartners company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Liberation Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Liberation Labs
2.2 - Growth funds investing in similar companies to Liberation Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Liberation Labs
4.2 - Public trading comparable groups for Liberation Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →